Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.39 |
| ▸ | GLI1 | P08151 | 5/20 | 0.37 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.35 |
| ▸ | SULT1E1 | P49888 | 1/20 | 0.33 |
| ▸ | TTL | Q8NG68 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.32 |
| ▸ | CDC25A | P30304 | 2/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26472022 | 0.89 | ALDH1A1 (0.53) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| Marrubenol SCHEMBL4450048 | 0.81 | ALDH1A1 (0.53) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL2784576 | 0.75 | ALDH1A1 (0.55) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL26472020 | 0.75 | ALDH1A1 (0.55) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL17301626 | 0.73 | ALDH1A1 (0.50) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL4456739 | 0.71 | ALDH1A1 (0.60) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL13446720 | 0.71 | ALDH1A1 (0.72) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL13446726 | 0.71 | ALDH1A1 (0.72) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL26472087 | 0.69 | ALDH1A1 (0.48) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 | |
| SCHEMBL30525934 | 0.69 | ALDH1A1 (0.47) | ALDH1A1MAPTUSP2CYP3A4HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180011401-A1 | SULFONIC ACID DERIVATIVE, PHOTOACID GENERATOR USING SAME, RESIST COMPOSITION, AND DEVICE MANUFACTURING METHOD | TOYO GOSEI CO., LTD. (JP) | 2018-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180011401-A1 | SULFONIC ACID DERIVATIVE, PHOTOACID GENERATOR USING SAME, RESIST COMPOSITION, AND DEVICE MANUFACTURING METHOD | ASIC1, ASIC3, CRY1 | ALDH1A1 565/4885MAPT 4292/4885USP2 2213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.